Posted: July 24, 2009

Leica Microsystems and A. Menarini Diagnostics Continue Their Successful Cooperation for Fast and Reliable Cancer Diagnosis

(Nanowerk News) Leica Microsystems GmbH and A. Menarini Diagnostics S.r.l. have signed a five-year agreement to extend their successful cooperation. According to this agreement, Menarini Diagnostics will continue to be the exclusive distributor in key European countries for Leica Microsystems’ automated immunohistochemistry (IHC) stainer, Leica BondTM as well as Leica Microsystems’ NovocastraTM antibodies and reagents.
The Leica BONDTM is the most flexible, fully-automated staining system on the market for immunohistochemistry-based cancer diagnosis. Used in combination with Leica Microsystems’ wellknown range of NovocastraTM antibodies, it allows fast, reliable and consistent staining of tissue samples (biopsies) to aid in the diagnosis and staging of cancer.
The distribution agreement between Leica Microsystems and Menarini Diagnostics succeeds a five-year contract between both companies. “We are pleased to be able to continue our successful partnership with Menarini Diagnostics. This partnership will allow our joint customers to benefit from Menarini’s strong sales force and customer support and from our world-class immunohistochemistry products. This partnership is key to our goal to further increase our market share in immunohistochemistry in Europe,” explains Dr. David Martyr, President Leica Microsystems.
Dr. Crescenzio Izzo, Managing Director A. Menarini Diagnostics confirms: “The renewal of this agreement confirms our approach to build strong partnerships with customers and Leica Microsystems, a leading company in R&D and Manufacturing of innovative product solutions. Our expert, specialized distribution organization covers a large part of the European diagnostics market. We have built our expertise in the Immunohistochemistry field for almost 20 years and we employ about 300 highly skilled people in sales, technical services and application support. Menarini takes its responsibility to the healthcare community seriously and strives to always provide the best solutions to its customers’ needs in the field of immunohistochemistry.”
About Leica Microsystems
Leica Microsystems is a leading global designer and producer of innovative, high-tech, precision optical systems for the analysis of microstructures as well as a broad product portfolio for histopathology. It is one of the market leaders in the business areas Microscopy, Confocal Laser Scanning Microscopy with corresponding Imaging Systems, Specimen Preparation, and Medical Equipment. The company manufactures a broad range of products for numerous applications requiring microscopic imaging, measurement, and analysis. It also offers system solutions for life science including biotechnology and medicine, research and development of raw materials, and industrial quality assurance. Furthermore, Leica Microsystems brings histopathology labs and researchers the highest quality, most comprehensive product portfolio. The range includes the ideal product for each histology step and high-productivity workflow solutions for the entire lab, supporting better patient care through rapid turnaround, diagnostic confidence and close customer collaboration. The company is represented in over 100 countries with 11 manufacturing facilities in 8 countries, sales and service organizations in 19 countries and an international network of dealers. The international management is headquartered in Wetzlar, Germany.
About A. Menarini Diagnostics
A. Menarini Diagnostics is a leading European healthcare company in the development of prevention and provider of innovative diagnostic solutions. The activities cover urinanalysis, autoimmune diseases, hematology, immunology, immunohistochemistry, wet and dry chemistry systems and it is a market leader in diabetes monitoring. The company aims to make diagnostics management easier, more effective and result cost efficient. All over Europe, more than 700 skilled scientific consultants are supporting each client. In Western Europe, the network covers 90% of the population and serves a market of 300 millions people. The company has over 13.000 employees in 70 countries, 13 fully owned subsidiaries, and in the future will also establish its presence in East and North of Europe. A. Menarini Diagnostics is part of the pharmaceutical Menarini Group and has its headquarters in Florence, Italy. =
Source: Leica Microsystems (press release)
Subscribe to a free copy of one of our daily
Nanowerk Newsletter Email Digests
with a compilation of all of the day's news.
These articles might interest you as well: